Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to compare maintenance therapy with pemetrexed plus BSC versus placebo plus BSC, in terms of the overall survival time (OS) in patients with Stage IIIB (with pleural effusion and/or positive supraclavicular lymph nodes) or IV NSCLC who have not progressed during four cycles of platinum?based induction chemotherapy.
Critère d'inclusion
- non-small cell lung cancer